Multidrug Resistance in Prostate Cancer

Oncology Research and Treatment - Switzerland
doi 10.1159/000071510
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Relationship Between Multidrug Resistance 1 Polymorphisms and the Risk of Prostate Cancer in Chinese Populations

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Multidrug Resistance Protein 1 Localization in Lipid Raft Domains and Prostasomes in Prostate Cancer Cell Lines

OncoTargets and Therapy
OncologyPharmacology
2014English

Starvation, Detoxification, and Multidrug Resistance in Cancer Therapy

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2012English

Targeting Multidrug Resistance in Cancer by Natural Chemosensitizers

Bulletin of the National Research Centre
2019English

Multidrug Resistance Proteins (MRPs) and Cancer Therapy

AAPS Journal
Pharmaceutical Science
2015English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Trametinib Modulates Cancer Multidrug Resistance by Targeting ABCB1 Transporter

Oncotarget
Oncology
2015English

Front Cover: Proteins Regulating Microvesicle Biogenesis and Multidrug Resistance in Cancer

Proteomics
BiochemistryMolecular Biology
2019English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy